Khavinson’s Epithalon Longevity Research Program

Background

Professor Vladimir Khavinson at the St. Petersburg Institute of Bioregulation and Gerontology has been the primary researcher behind epithalon for 35+ years. His work on “peptide bioregulation” posits that short peptides (2-4 amino acids) can interact directly with DNA to modulate gene expression.

Key Findings Across Program

1. Rat Lifespan: Epithalamin (natural pineal extract, precursor to synthetic epitalon) extended both median and maximum lifespan in rats
2. Human Geriatric Studies: 15+ year follow-up of elderly patients receiving epithalamin showed improved biomarkers
3. Melatonin Restoration: Elderly patients showed normalized melatonin rhythms after epithalon treatment
4. Telomerase Activation: Epithalon activated telomerase in human somatic cells in vitro
5. Pineal Gland Function: Epithalon counteracted age-related pineal calcification effects

Limitations

• Most research published in Russian journals with limited peer review in Western literature
• Study designs often lack the rigor expected by FDA standards
• Confounding variables in longitudinal human studies
• Mechanism of direct peptide-DNA interaction remains controversial

Relevance

Provides the foundational evidence base for Epithalon use in longevity protocols. While the evidence quality is mixed, the consistency across 35 years of research and the recent Western validation of telomerase activation (PMID: 40908429) lend credibility to the core claims.

See Also

• Parent compound: Epithalon
• Related compound: NAD+ (comprehensive longevity: telomere + mitochondrial/sirtuin)
• Related compound: SS-31 (mitochondrial longevity stack partner)